Literature DB >> 14578361

Phosphatidylinositide 3-kinase priming couples c-FLIP to T cell activation.

Li-Wen Fang1, Tzong-Shyuang Tai, Wan-Ni Yu, Fang Liao, Ming-Zong Lai.   

Abstract

Cellular FLICE (FADD-like interleukin-1-beta-converting enzyme)-inhibitory protein (c-FLIP) inhibits death receptor-induced apoptosis by binding to FADD (Fas-associated death domain protein) and pro-caspase-8. c-FLIP has also been shown to transmit activation signals and to enhance interleukin (IL)-2 production. However, c-FLIP-mediated T cell activation is difficult to detect in most cells. We found that in DO11.10 T cells, c-FLIP expression led to inhibition of IL-2 production, in contrast to the readily detectable c-FLIP-induced activation in Jurkat cells. A direct comparison revealed that distinct signal pathways were regulated by c-FLIP in Jurkat cells and DO11.10 cells. We investigated whether constitutively activated phosphatidylinositide 3-kinase (PI3K) in Jurkat cells stimulated c-FLIP. Inhibition of PI3K in Jurkat cells abrogated a c-FLIP-mediated increase in IL-2 production. In addition, c-FLIP coordinated with active PI3K for ERK activation. Furthermore, introduction of PTEN back into Jurkat cells eliminated the stimulatory effect of c-FLIP on IL-2 production and ERK activation. Our results suggest that priming with PI3K promotes the coupling of c-FLIP to T cell activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578361     DOI: 10.1074/jbc.M303860200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Deguelin, an Akt inhibitor, down-regulates NF-κB signaling and induces apoptosis in colon cancer cells and inhibits tumor growth in mice.

Authors:  Hyoun Woo Kang; Jung Mogg Kim; Mi Yeon Cha; Hyun Chae Jung; In Sung Song; Joo Sung Kim
Journal:  Dig Dis Sci       Date:  2012-05-24       Impact factor: 3.199

2.  Deltex regulates T-cell activation by targeted degradation of active MEKK1.

Authors:  Wen-Hsien Liu; Ming-Zong Lai
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 3.  Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy.

Authors:  Ahmad R Safa; Travis W Day; Ching-Huang Wu
Journal:  Curr Cancer Drug Targets       Date:  2008-02       Impact factor: 3.428

Review 4.  c-FLIP, a master anti-apoptotic regulator.

Authors:  A R Safa
Journal:  Exp Oncol       Date:  2012-10

5.  Allogeneic transplantation, Fas signaling, and dysregulation of hepcidin.

Authors:  Xiang Li; Feng Xu; Ekapun Karoopongse; A Mario Marcondes; Kayoung Lee; Kris V Kowdley; Carol H Miao; Grant D Trobridge; Jean S Campbell; H Joachim Deeg
Journal:  Biol Blood Marrow Transplant       Date:  2013-05-22       Impact factor: 5.742

6.  Participation of c-FLIP in NLRP3 and AIM2 inflammasome activation.

Authors:  Y-H Wu; W-C Kuo; Y-J Wu; K-T Yang; S-T Chen; S-T Jiang; C Gordy; Y-W He; M-Z Lai
Journal:  Cell Death Differ       Date:  2013-11-22       Impact factor: 15.828

7.  Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.

Authors:  Ahmad R Safa; Karen E Pollok
Journal:  Cancers (Basel)       Date:  2011-06       Impact factor: 6.639

8.  Absence of the Adaptor Protein PEA-15 Is Associated with Altered Pattern of Th Cytokines Production by Activated CD4+ T Lymphocytes In Vitro, and Defective Red Blood Cell Alloimmune Response In Vivo.

Authors:  Stéphane Kerbrat; Benoit Vingert; Marie-Pierre Junier; Flavia Castellano; François Renault-Mihara; Silvina Dos Reis Tavares; Mathieu Surenaud; France Noizat-Pirenne; Jorge Boczkowski; Georges Guellaën; Hervé Chneiweiss; Sabine Le Gouvello
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

9.  NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP.

Authors:  Sebastian Kreuz; Daniela Siegmund; Jost-Julian Rumpf; Dierk Samel; Martin Leverkus; Ottmar Janssen; Georg Häcker; Oliver Dittrich-Breiholz; Michael Kracht; Peter Scheurich; Harald Wajant
Journal:  J Cell Biol       Date:  2004-08-02       Impact factor: 10.539

10.  hnRNPK inhibits GSK3β Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells.

Authors:  Xuejuan Gao; Junxia Feng; Yujiao He; Fengmei Xu; Xiaoqin Fan; Wensi Huang; Haiting Xiong; Qiuyu Liu; Wanting Liu; Xiaohui Liu; Xuesong Sun; Qing-Yu He; Qihao Zhang; Langxia Liu
Journal:  Sci Rep       Date:  2016-03-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.